Mesh ablator vs. cryoballoon pulmonary vein ablation of symptomatic paroxysmal atrial fibrillation: Results of the MACPAF study

Europace

Volumn 14, Issue 10, 2012, Pages 1441-1449

  Koch, Lydia ^a   Haeusler, Karl Georg ^a   Herm, Juliane ^a   Safak, Erdal ^a   Fischer, Robert ^a   Malzahn, U ^a,b   Werncke, Thomas ^a   Heuschmann, Peter U ^a,b   Endres, Matthias ^a   Fiebach, Jochen B ^a   Schultheiss, Heinz Peter ^a   Schirdewan, Alexander ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Atrial fibrillation; Catheter ablation; Cryoballoon; Mesh ablator; Pulmonary vein

Indexed keywords

ADULT; AGED; ARTICLE; BALLOON CATHETER; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE SAFETY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; PULMONARY VEIN ISOLATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; CRYOSURGERY; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY VEINS; RECURRENCE; SURGICAL MESH; TREATMENT OUTCOME;

EID: 84866931876     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus084     Document Type: Article

References (17)

1. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12:1360-420.
2. Cappato R, Calkins H, Chen S-A, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
3. Klein G, Oswald H, Gardiwal A, Lsebrink U, Lissel C, Yu H, et al. Efficacy of pulmonary vein isolation by cryoballoon ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm 2008;5:802-6.
4. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, et al. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008; 52:273-8.
5. Belle Y Van, Janse P, Rivero-Ayerza MJ, Thornton AS, Jessurun ER, Theuns D, et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J 2007;28: 2231-7.
6. Van Belle Y, Janse P, Theuns D, Szili-Torok T, Jordaens L. One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation. Europace 2008;10:1271-6.
7. Chun KRJ, Schmidt B, Metzner A, Tilz R, Zerm T, Kö ster I, et al. The 'single big cryoballoon' technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J 2009;30:699-709.
8. Chun KRJ, Frnkranz A, Metzner A, Schmidt B, Tilz R, Zerm T, et al. Cryoballoon pulmonary vein isolation with real-time recordings from the pulmonary veins. J Cardiovasc Electrophysiol 2009;20:1203-10.
9. Andrade JG, Khairy P, Guerra PG, Deyell MW, Rivard L, Macle L, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies. Heart Rhythm 2011;8:1444-51.
10. Mansour M, Forleo GB, Pappalardo A, Heist EK, Avella A, Laurenzi F, et al. Initial experience with the Mesh catheter for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Heart Rhythm 2008;5:1510-6.
11. Haeusler KG, Koch L, Ueberreiter J, Endres M, Schultheiss H-P, Heuschmann PU, et al. Stroke risk associated with balloon based catheter ablation for atrial fibrillation: rationale and design of the MACPAF study. BMC Neurol 2010;10:63.
12. Haeusler KG, Koch L, Ueberreiter J, Coban N, Safak E, Kunze C, et al. Safety and reliability of the insertable Reveal XT recorder in patients undergoing 3 Tesla brain magnetic resonance imaging. Heart Rhythm 2011;8:373-6.
13. De Greef Y, Tavernier R, Duytschaever M, Stockman D. Pulmonary vein isolation with the 30 and 35 mm high-density mesh ablator. Europace 2010;12: 1428-34.
14. Steinwender C, Hö nig S, Leisch F, Hofmann R. Acute results of pulmonary vein isolation in patients with paroxysmal atrial fibrillation using a single mesh catheter. J Cardiovasc Electrophysiol 2009;20:147-52.
15. Hofmann R, Hö nig S, Leisch F, Steinwender C. Pulmonary vein isolation with Mesh Ablator versus cryoballoon catheters: 6-month outcomes. J Interv Card Electrophysiol 2010;29:179-85.
16. Maagh P, Bracht M van, Butz T, Trappe H-J, Meissner A. Eighteen months followup of the clinical efficacy of the high density mesh ablator (HDMA) in patients with atrial fibrillation after pulmonary vein isolation. J Interv Card Electrophysiol 2010;29:43-52.
17. Khne M, Schaer B, Ammann P, Suter Y, Osswald S, Sticherling C. Cryoballoon ablation for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. Swiss Med Wkly 2010;140:214-21.